| Use in Burn and Reconstructive
Surgery |
|
In 1996, the US Food and Drug Administration
(FDA) approved the use of INTEGRA® Dermal Regeneration
Template for the treatment of life threatening burn injuries.
Since then, nearly 10,000 patients have been successfully
treated using the INTEGRA Template.
In 2002, the FDA approved the use of INTEGRA Template
to include the reconstruction of scar contractures. This
new indication provides relief for thousands of individuals
living with disabling scarring from prior burns.
Indications for Use - U.S.A.
Burns
INTEGRA® Dermal Regeneration
Template is indicated for the post-excisional treatment
of life threatening full-thickness or deep partial-thickness
thermal injuries where sufficient autograft is not available
at the time of excision or not desirable due to the physiological
condition of the patient.
Reconstruction
INTEGRA® Dermal Regeneration Template is indicated
for the repair of scar contractures when other therapies
have failed, or when donor sites for repair are not sufficient
or desirable due to the physiological condition of the
patient.
